Skip to content

Clinical trials

Adenocarcinoma of Lung trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma of Lung Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20122
20132
20151
20171
20192
20201
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated3
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
European Organisation for Research and Treatment of Cancer - EORTC2
Pfizer2
Amgen1
AstraZeneca1
BerGenBio ASA1
Royal Cornwall Hospitals Trust1
UNICANCER1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma of Lung15
Carcinoma, Non-Small-Cell Lung10
Lung Neoplasms8
Adenocarcinoma, Bronchiolo-Alveolar2
Squamous Cell Carcinoma of Head and Neck2
Breast Neoplasms1
Carcinoma, Ovarian Epithelial1
Carcinoma, Transitional Cell1
Cholangiocarcinoma1
Colorectal Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.